Take Solutions (NSE:TAKE) Debt-to-Asset : 0.42 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Take Solutions Debt-to-Asset?

Take Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹305.1 Mil. Take Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹65.8 Mil. Take Solutions's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₹881.1 Mil. Take Solutions's debt to asset for the quarter that ended in Mar. 2024 was 0.42.

Take Solutions Debt-to-Asset Historical Data

The historical data trend for Take Solutions's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions Debt-to-Asset Chart

Take Solutions Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.24

0.30

0.06

0.21

0.42

Take Solutions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.21	-	0.20	-	0.42

Competitive Comparison of Take Solutions's Debt-to-Asset

For the Biotechnology subindustry, Take Solutions's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Take Solutions's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Take Solutions's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Take Solutions's Debt-to-Asset falls into.

Take Solutions Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Take Solutions's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(305.06	+	65.79)	/	881.05
	=	0.42

Take Solutions's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(305.06	+	65.79)	/	881.05
	=	0.42

Take Solutions (NSE:TAKE) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Take Solutions Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Take Solutions's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Take Solutions (NSE:TAKE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (NSE:TAKE) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

532890:India

Address

No. 27, Tank Bund Road, Nungambakkam, Chennai, TN, IND, 600 034

Website

https://www.takesolutions.com

Take Solutions Ltd is a technology-driven Clinical Research Organization in India. The company's operating segment includes Life Sciences and generates revenue from the Life Sciences segment. The company serves large and small biopharmaceutical companies as well as generics manufacturers.

Take Solutions (NSE:TAKE) Headlines

No Headlines